A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CCM / cardiac contractility modulation

[Related PubMed/MEDLINE]
Total Number of Papers: 74
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CCM  (>> Co-occurring Abbreviation)
Long Form:   cardiac contractility modulation
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Cardiac Contractility Modulation Attenuates Chronic Heart Failure in a Rabbit Model via the PI3K/AKT Pathway. HF
2020 Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System: The FIX-HF-5C2 Study. ---
2019 Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients. 6MHWT, BAT, HF, HFrEF, MLHFQ, NYHA, OMT
2019 Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction. HF, MLHFQ, NYHA, SHFM
2019 Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond. EF, HF, HFmrEF, HFrEF
2019 Inappropriate Defibrillator Shocks due to Mechanical Inference from an Investigational Device. CRT
2019 New Generation Cardiac Contractility Modulation Device-Filling the Gap in Heart Failure Treatment. AF, CRT, HF, HFrEF, ICD, LVEF, NYHA
2019 Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. 6MWD, HF, MLHFQ, OR, RCTs, SMD
2019 [Device-device interaction]. BAT, CIED, ECG, ICD, PM, S-ICD, WCD
10  2018 A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation. ET, HF, NYHA
11  2018 Cardiac contractility modulation improves left ventricular systolic function partially via miR-25 mediated SERCA2A expression in rabbit trans aortic constriction heart failure model. HF, HF, LV, LVEF, RT-PCR, SHM, TAC
12  2018 Device therapy in heart failure with reduced ejection fraction-cardiac resynchronization therapy and more. ARNI, BAT, CRT, HFrEF, LBBB
13  2018 Heart failure with preserved ejection fraction: current management and future strategies : Expert opinion on the behalf of the Nucleus of the "Heart Failure Working Group" of the German Society of Cardiology (DKG). BAT, HF, IASD
14  2018 Long-term results of combined cardiac contractility modulation and subcutaneous defibrillator therapy in patients with heart failure and reduced ejection fraction. HFrEF, ICD, LVEF, S-ICD
15  2018 [Cardiac contractility modulation for treatment of chronic heart failure]. ACE, ARB, ARNI, BB, FDA, LV, MRA
16  2018 [Cardiac contractility modulation]. LV
17  2017 An updated review of cardiac devices in heart failure. CRT, MCS, VADs
18  2017 Cardiac contractility modulation in heart failure patients: Randomized comparison of signal delivery through one vs. two ventricular leads. HF, NYHA
19  2017 Cardiac Contractility Modulation: A Technical Guide for Device Implantation. ---
20  2017 Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction. ---
21  2017 The safety and efficacy of cardiac contractility modulation in heart failure : Ameta-analysis of clinical trials. CIs, HF, RR, SMD
22  2016 A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report. 6MWD, EF, MLWHFQ, NYHA
23  2016 Cardiac Contractility Modulation Attenuate Myocardial Fibrosis by Inhibiting TGF-beta1/Smad3 Signaling Pathway in a Rabbit Model of Chronic Heart Failure. CHF
24  2016 Cardiac contractility modulation: a novel approach for the treatment of heart failure. ARB
25  2016 Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study. EF, HF
26  2016 Long-term survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration. ---
27  2015 A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design. EF, NYHA, OMT, VAT
28  2015 Heart Failure With Reduced Ejection Fraction And A Narrow QRS Complex: Combination Of A Subcutaneous Defibrillator With Cardiac Contractility Modulation. ICD, S-ICD
29  2015 Implementation of Contraction to Electrophysiological Ventricular Myocyte Models, and Their Quantitative Characterization via Post-Extrasystolic Potentiation. CRT, HF
30  2015 Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices. CIEDs, S-ICD
31  2015 [Cardiac contractility modulation. A new form of therapy for patients with heart failure and narrow QRS complex?]. ---
32  2014 Biventricular pacing cardiac contractility modulation improves cardiac contractile function via upregulating SERCA2 and miR-133 in a rabbit model of congestive heart failure. BVP-CCM, FS, LVEDD, LVEF, LVESD, LVP-CCM, SERCA2a
33  2014 Cardiac contractility modulation increases action potential duration dispersion and decreases ventricular fibrillation threshold via beta1-adrenoceptor activation in the crystalloid perfused normal rabbit heart. HF, MAPD, VFT
34  2014 Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation. AF, CRT, HF, ICD
35  2014 Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials. CIs, HF
36  2014 Long term impact of cardiac contractility modulation on QRS duration. ---
37  2013 Cardiac contractility modulation in patients with advanced heart failure. ---
38  2013 Cardiac contractility modulation therapy in advanced systolic heart failure. ---
39  2013 Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations. CRT, LV, LVESV
40  2012 Cardiac contractility modulation device-new hope for refractory heart failure patients. HF
41  2012 Cardiac contractility modulation for heart failure: a meta-analysis of randomized controlled trials. CIs, HF, RRs
42  2012 Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure. CRT
43  2012 The effect of device-based cardiac contractility modulation therapy on myocardial efficiency and oxidative metabolism in patients with heart failure. MBF, PET
44  2011 A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. EF, MLWFQ, OMT, VAT
45  2011 Cardiac contractility modulation in the treatment of heart failure: initial results and unanswered questions. ---
46  2011 Does contractility modulation have a role in the treatment of heart failure? CRT, NYHA
47  2011 Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure. ---
48  2011 Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. OMT, VAT
49  2011 The acute inotropic effects of cardiac contractility modulation (CCM) are associated with action potential duration shortening and mediated by beta1-adrenoceptor signalling. LVP, MAPD
50  2011 [Improving left ventricular contraction by stimulation during the absolute refractory period. Cardiac contractility modulation]. ---
51  2011 [Treating congestive heart failure with cardiac contractility modulation (CCM) : possibilities and study overview]. ICD
52  2009 Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals. CSQ, HF, LV, NL, PS1
53  2009 Cardiac contractility modulation electrical signals normalize activity, expression, and phosphorylation of the Na+-Ca2+ exchanger in heart failure. HF, NCX-1, NL, P-NCX
54  2009 Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling. LV, NYHA
55  2009 [Cardiac contractility modulation: a new option for treating systolic heart failure]. ---
56  2008 A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. ---
57  2008 Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. MHC
58  2008 Cardiac contractility modulation in non-responders to cardiac resynchronization therapy. CRT, CS, LV, NR, NYHA
59  2008 Effects of chronic therapy with cardiac contractility modulation electrical signals on cytoskeletal proteins and matrix metalloproteinases in dogs with heart failure. HF, LV, MMPs, NL, TIMPs
60  2008 Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. EF, MLWHFQ
61  2008 [Improving left ventricular contractility by stimulation during the absolute refractory period--cardiac contractility modulation (CCM)]. CRT
62  2007 Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption. HF, LV
63  2007 First use of cardiac contractility modulation (CCM) in a patient failing CRT therapy: clinical and technical aspects of combined therapies. CRT
64  2007 Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure. EF, HF, LV, MET-ER
65  2006 Treating heart failure with cardiac contractility modulation electrical signals. HF
66  2005 Electrical signals applied during the absolute refractory period: an investigational treatment for advanced heart failure in patients with normal QRS duration. NYHA
67  2004 Cardiac contractility modulation by non-excitatory electrical currents. The new frontier for electrical therapy of heart failure. HF
68  2004 Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. ---
69  2004 First human chronic experience with cardiac contractility modulation by nonexcitatory electrical currents for treating systolic heart failure: mid-term safety and efficacy results from a multicenter study. 6MWT, EF, HF, MLWHFQ, NYHA
70  2004 Long-term effects of non-excitatory cardiac contractility modulation electric signals on the progression of heart failure in dogs. EDV, EF, ESV, HF
71  2003 Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure. HF
72  2002 Cardiac contractility modulation by electric currents applied during the refractory period in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. BVP, HF, LV, RV
73  2002 Cardiac contractility modulation by electric currents applied during the refractory period. ---
74  2001 Cardiac contractility modulation with the impulse dynamics signal: studies in dogs with chronic heart failure. LV